PenTriple-G 10 mg
A growth-peptide research blend studied for the GH/IGF-1 axis and recovery endpoints.
PANCRAGEN PENMetabolic · Bioregulator
A short peptide bioregulator of pancreatic origin studied for its role in normalising pancreatic cell function and carbohydrate-metabolism endpoints in research models.
Available to verified researchers. Pricing and the batch Certificate of Analysis are shared on request.
Pancragen is a peptide bioregulator studied for supporting normal pancreatic cell activity and for its prospective role in metabolic and glucose-regulation research models.
Features
Pancragen is supplied in the NADOVA LABS GoQuick pre-filled pen — a graduated, ready-to-use subcutaneous delivery format that removes reconstitution and simplifies repeat-dose study designs. Each pen is prepared from HPLC-verified material, dose-marked on the barrel, and shipped refrigerated with a Certificate of Analysis available per batch.
Handling & compliance
This pre-filled pen is intended strictly for in-vitro and laboratory research. It is not a drug, supplement, or medical device, and is not for human or veterinary use. Store refrigerated at 2–8 °C, protect from light, and follow accepted laboratory practice; exact specifications for your lot are listed on its Certificate of Analysis.
PenA growth-peptide research blend studied for the GH/IGF-1 axis and recovery endpoints.
PenThe higher-strength growth-peptide blend for GH/IGF-1 axis research.
PenA GHRH analog studied for sustained growth-hormone-axis stimulation research.
Request a researcher account to view the Certificate of Analysis for this lot and place an order with the lab.